AbbVie Acquires Aliada Therapeutics for $1.4B to Advance Alzheimer's Treatment In a bold move to cement its position in neuroscience innovation, AbbVie has officially acquired Aliada Therapeutics, a trailblazing biotech company, for $1.4 billion.

www.linkedin.com/pulse/abbvie...

AbbVie Acquires Aliada Therapeutics for $1.4B to Advance Alzheimer's Treatment

kstrategyand.com

#AbbVie #AliadaTherapeutics #AlzheimersDisease #HealthcareInnovation #Neuroscience #DiseaseModification #Humanteconomy #Humantec #KStrategyand